McDevitt Damien 4
4 · AKCEA THERAPEUTICS, INC. · Filed Oct 13, 2020
Insider Transaction Report
Form 4
McDevitt Damien
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2020-10-12$5.39/sh−120,000$646,800→ 0 totalExercise: $12.76Exp: 2030-03-18→ Common Stock (120,000 underlying) - Disposition from Tender
Common Stock
2020-10-12$18.15/sh−242,978$4,410,051→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2020-10-12$5.39/sh−200,000$1,078,000→ 0 totalExercise: $12.76Exp: 2030-03-18→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]This option, which provided that 1/4th of the shares would vest one year after March 19, 2020 and 1/48th of the shares would vest monthly thereafter over the next three years, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $646,800.00, representing the difference between the exercise price of the option and the acquisition price of $18.15.
- [F2]This option, which provided that 1/4th of the shares would vest one year after March 19, 2020 and 1/48th of the shares would vest monthly thereafter over the next three years, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $1,078,000.00, representing the difference between the exercise price of the option and the acquisition price of $18.15.